CNTB vs KIM · rev $64.0K vs P/E 27, rev $1.11B
Connect Biopharma Holdings Ltd (CNTB) versus Kimco Realty Corporation (KIM) — a side-by-side from cached financials, not a winner call.
Connect Biopharma Holdings Ltd (CNTB) is a biotechnology company listed on US.
Kimco Realty Corporation (KIM) is a reit - retail company listed on US.
Latest reported CNTB revenue for 2025-12-31 was $64.0K. Net income was -$55.5M. Revenue was down 99.8% from 2024-12-31 to 2025-12-31. CNTB currently screens at market cap $63.3M.
Latest reported KIM revenue for 2026-06-30 was $1.11B. Net income was $318.2M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
CNTB currently screens at market cap $63.3M. KIM currently screens at market cap $16.03B and trailing P/E 27.3.
Not investment advice. Open the CNTB and KIM stock pages for the full models.
Not investment advice.